Overview
Nicole Nuesgen practices practicing medicine in Bonn, Germany.
Her clinical expertise encompasses Hemophilia A, Blood Clots, Klinefelter Syndrome, and Turner Syndrome.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nicole Nuesgen
Is Nicole Nuesgen a top-rated expert for Hemophilia A?
MediFind is an objective health platform that identifies experts based on real-world data. Nicole Nuesgen is classified as an Experienced expert for Hemophilia A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nicole Nuesgen participate in research or clinical trials?
Yes. Nicole Nuesgen has published 9 articles and abstracts on conditions like Hemophilia A. You can view a list of Nicole Nuesgen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Blood ClotsMs. Nuesgen isExperienced. Learn about Blood Clots.
- Hemophilia AMs. Nuesgen isExperienced. Learn about Hemophilia A.
- Klinefelter SyndromeMs. Nuesgen isExperienced. Learn about Klinefelter Syndrome.
- Turner SyndromeMs. Nuesgen isExperienced. Learn about Turner Syndrome.